Thanks stokdog!
Goodness me, a number of take aways from that, chock full of info. This will be a rather useful resource, though pending announcements, maybe small cheese.
Just a couple of quick things.
If you are chasing CHF rights outside of China, probably too late, being snaffled.
And the issue of sorting out reimbursement rates in a timely manner with approval/registration, this for the aGVHD solution. In relation to the speed bump Takeda are having at the moment.
Cell Therapy News/Articles, page-193
-
- There are more pages in this discussion • 17,607 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.3¢ |
Change
-0.018(1.77%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 94.3¢ | $4.452M | 4.606M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 33500 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 228046 | 13 |
View Market Depth
| Last trade - 14.18pm 01/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |